Bupivacaine Epiphora Trial
NCT03266081
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
No patients
Conditions
Epiphora
Ptosis
Interventions
DRUG:
0.75% bupivacaine
Sponsor
McMaster University